New program aims to close colorectal cancer screening gap for Low-Income and minority communities
NCT ID NCT06090643
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a culturally tailored program to increase colorectal cancer screening among low-income and ethnic minority groups, who are disproportionately affected by the disease. Nearly 10,000 patients aged 50-75 will receive education, consultations, and fecal immunochemical test (FIT) kits. The goal is to improve screening rates and catch cancer earlier, when it's easier to treat.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fecal immunochemical test (FIT) screening program
What this could lead to
If successful, this program could significantly increase colorectal cancer screening rates in underserved communities, helping detect cancer earlier and reduce health disparities.
What could go wrong
This is an implementation study, not a test of a new treatment. Success depends on real-world uptake, and results may not apply to other settings or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States